Allianz Asset Management
NTLA icon

Allianz Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Allianz Asset Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,400
Closed -$276K – 2237
2023
Q1 		$276K Buy
+7,400
New +$290K ﹤0.01% 2000
2022
Q3 		– Sell
-96,118
Closed -$4.97M – 2041
2022
Q2 		$4.97M Buy
96,118
+23,266
+32% +$1.18M ﹤0.01% 1104
2022
Q1 		$5.29M Sell
72,852
-9,888
-12% -$838K ﹤0.01% 1198
2021
Q4 		$9.8M Buy
82,740
+5,245
+7% +$657K 0.01% 997
2021
Q3 		$10.4M Buy
77,495
+27,354
+55% +$4.14M 0.01% 1002
2021
Q2 		$8.12M Buy
50,141
+11,972
+31% +$932K 0.01% 928
2021
Q1 		$3.06M Sell
38,169
-3,520
-8% -$236K ﹤0.01% 1244
2020
Q4 		$2.27M Buy
+41,689
New +$1.51M ﹤0.01% 1278
2020
Q2 		– Sell
-68,595
Closed -$839K – 2486
2020
Q1 		$839K Sell
68,595
-34,588
-34% -$466K ﹤0.01% 1862
2019
Q4 		$1.51M Buy
103,183
+11,794
+13% +$164K ﹤0.01% 2003
2019
Q3 		$1.22M Sell
91,389
-92,314
-50% -$1.47M ﹤0.01% 2037
2019
Q2 		$3.01M Buy
183,703
+12,778
+7% +$201K ﹤0.01% 1729
2019
Q1 		$2.92M Buy
170,925
+42,533
+33% +$634K ﹤0.01% 1691
2018
Q4 		$1.75M Buy
128,392
+6,738
+6% +$125K ﹤0.01% 1811
2018
Q3 		$3.48M Buy
121,654
+41,765
+52% +$1.22M ﹤0.01% 1721
2018
Q2 		$2.19M Buy
+79,889
New +$1.94M ﹤0.01% 1905

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Allianz Asset Management's NTLA Position: Q2 2023 in Review

Allianz Asset Management sold out of Intellia Therapeutics (NTLA) in Q2 2023, closing a stake of 7,400 shares — an estimated $276K sold.

Allianz Asset Management first reported a position in NTLA in Q2 2018 and held it in 16 quarters. The position peaked at $10.4M in Q3 2021. 290 funds tracked by Wall St. Rank hold NTLA as of Q2 2023.

  • Allianz Asset Management reported no remaining Intellia Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Allianz Asset Management sold 7,400 Intellia Therapeutics shares in Q2 2023, an estimated $276K.
  • Allianz Asset Management first reported a position in Intellia Therapeutics in Q2 2018 and held it in 16 quarters.
  • Allianz Asset Management's Intellia Therapeutics position peaked at $10.4M in Q3 2021.
  • 290 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2023.

Based on Allianz Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.